Vir Biotechnology Inc Cash Flow Quality Index
Vir Biotechnology Inc cash flow quality index. Vir Biotechnology Inc (VIR) has a Cash Flow Quality Index of 1.54x as of June 2026. Operating cash flow of $123.33 Million exceeds net income of $80.08 Million, indicating high earnings quality where cash backs reported profits. See Vir Biotechnology Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Vir Biotechnology Inc (2021–2022)
Cash flow quality index of Vir Biotechnology Inc from 2021 to 2022. Historical Cash Flow Quality Index for Vir Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Vir Biotechnology Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Vir Biotechnology Inc Cash Flow Quality Index by Year (2021–2022)
Vir Biotechnology Inc cash flow quality index by year from 2021 to 2022. Year-by-year earnings quality comparison for Vir Biotechnology Inc. For the full cash flow conversion analysis, see VIR cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.22x | $1.66 Billion | $515.84 Million | ▲ +3681.4% |
| 2021 | -0.09x | $-47.59 Million | $528.58 Million | — |